Carevoyance, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Carevoyance, Inc. - overview
Established
2014
Location
Portland, OR, US
Primary Industry
Healthcare IT
About
Based in Oregon, US, and founded in 2014 by CEO Anatoly Geyfman, and CTO Daniel Imfeld, Carevoyance, Inc. , a. k. a.
Carevoyance is a provider of sales acceleration engines that automates multiple phases of sales cycle conducted by commercial teams to offer data-driven targeting, sales enablement, and physician segmentation insights and assets. In August 2021, H1 Insights, Inc. , a portfolio company of Menlo Ventures, Underscore VC, Y Combinator, Institutional Venture Partners, Lux Capital, and Transformation Capital acquired Carevoyance, Inc. The company provides targeting, sales enablement, and physician segmentation platform for medical device sellers to access workflows designed for sales teams, pre-configured with deep healthcare data.
The platform allows clients to find targeted hospitals and doctors based on procedures, diagnoses, prescriptions, quality, industry relationships, and more. In addition, the platform offers multiple features, including a territory manager, integrated contacts, clean healthcare directories, data sources, and more.
Current Investors
H1 Insights, Inc.
Primary Industry
Healthcare IT
Sub Industries
Healthcare IT, Analytics & Performance Software, Sales & Marketing Software
Website
www.carevoyance.com
Verticals
Cloud Computing, HealthTech
Company Stage
Add-on
Total Amount Raised
Subscriber access only
Carevoyance, Inc. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.